Marina joined Ampersand in 2013. Most recently she was an Associate Director in Healthcare Investment Banking at UBS where she worked on a number of leveraged buyouts, mergers and acquisitions, and debt and equity financings for middle market healthcare companies. Prior to joining UBS, Marina worked at biochemistry laboratories at Harvard Medical School and Wellesley College. Marina’s current and past board seats include Gyros PTI and Vibalogics. Marina holds a B.A. with Honors from Wellesley where she majored in Biological Chemistry and International Relations.